IBH Uses AI and Clinical Data Analytics to Shape the Future of Behavioral Healthcare in Partnership with Lyssn
IBH Population Health Solutions, a national leader in behavioral health technology and services, announced the launch of its new Provider Clinical Data Analytics technology platform that uses artificial intelligence (AI) and machine learning to improve the quality and outcomes of talk therapy counseling. This program was developed in partnership with Lyssn (Lyssn.io, Inc.) and is the newest initiative to come from IBH’s Dysruption lab, a corporate incubator IBH created to rapidly prototype and deploy new clinically validated advancements in healthcare delivery.
Lyssn creates AI-enabled technology solutions that can examine and support the effectiveness of therapy by offering ongoing feedback and skill development for psychotherapy professionals. Practice variability is high and conformance to evidence-based protocols is particularly difficult to assess in care that is delivered via the spoken word.
“Understanding what is working well at the individual practice level and using technology to glean clinical insight to make care better for all can be transformative to improving outcomes and identifying best practices for a variety of mental health conditions,” said Dan Clark, CEO of IBH. “Technology has the ability to improve access and quality by helping therapists be the best they can be, and that’s exactly what we’re exploring with Lyssn.”
Recommended AI News: Nasuni Secures $40 Million In New Financing As The Pandemic Accelerates The Enterprise Shift To The Public Cloud
More than 60 million people currently suffer from mental illness or addiction, which equates to one out of every five U.S. residents, and many see a counselor for talk therapy. The Provider Clinical Data Analytics Program combines advanced technologies to extract clinically meaningful information from recorded talk therapy counseling sessions on a HIPAA and FERPA compliant recording system. The platform then translates recordings of conversations into data and uses AI technologies to analyze the interactions and generate metrics to determine if providers are using the best evidence-based practices in their treatments.
Recommended AI News: Yellowfin Accelerates The Development Of Analytical Applications With New Release
By combining the collective knowledge of thousands of therapists across the country, IBH can learn from the work its clinicians are doing with their clients and provide high-quality, performance-based feedback to support IBH providers and in turn, improve the outcomes for patients. All patients and providers who are participating in the program give explicit consent to analyze sessions for the purpose of improving care during the research trial and understand that their information remains completely private, is encrypted, anonymized and secured with military-grade, block-chain security measures.
“As the behavioral health crisis continues to rise in the United States, the need for high-quality mental healthcare is evident now more than ever before,” said Dave Atkins, CEO of Lyssn. “At Lyssn, our goal is to use innovative technology to provide clinically meaningful and ongoing feedback to support therapists and help them continuously improve and support patients to the best of their abilities. We believe this can become an important tool to help providers get valuable feedback and training to improve care for all.”
Recommended AI News: Azure Databricks Now Available On Microsoft Azure Government
Comments are closed, but trackbacks and pingbacks are open.